Clinical TrialsSearch results
Number of results: 221
Other
- Japanese multicenter, randomized trial of endoscopic stenting for the nonresectable pancreatic head cancer (JM-Test)
- nonresectable pancreatic head cancer
- Faculty of Medicine, University of Tokyo
- 2006-04-01
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Phase II study of gefitinib in untreated advanced non-small cell lung cancer with EGF receptor mutations
- non-small cell lung cancer
- Hokkaido Lung Cancer Clinical Study Group
- 2005-09-12
Other
- Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer
- Non-small cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer
- non-small cell lung cancer
- Japanese Northern East Area Thoracic Surgery Study Group
- 2007-08-01
Other
- Randomized phase III study of Standard CHOP(S-CHOP) versus Biweekly CHOP(Bi-CHOP) in aggressive Non-Hodgkin's Lymphoma(JCOG9809)
- Non-Hodgkin's lymphoma
- Japan Clinical Oncology Group(JCOG)
- 2005-08-04
Other
- A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.
- Non small cell lung cancer
- Fukushima Medical University
- 2006-04-01
Other
- Randomized phase II trial of Carboplatin/Gemcitabine versus Cisplatin/Gemcitabine for the patient with completely resected pathological stage IB-IIIA of Non Small Cell Lung Cancer
- Non Small Cell Lung Cancer
- Hokkaido Lung Cancer Clinical Study Group
- 2007-11-29
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07